Top compounds associated with response to NCALD


Feature Type Standardized
Nominal ANOVA
mRNA GSK429286A GDSC1000 pan-cancer AAC -0.097 0.004
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.004
mRNA foretinib GDSC1000 pan-cancer AAC -0.096 0.004
mRNA GSK-650394 GDSC1000 pan-cancer AAC -0.11 0.004
mRNA Gemcitabine GDSC1000 pan-cancer AAC -0.1 0.005
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.005
mRNA Camptothecin GDSC1000 pan-cancer AAC -0.097 0.005
mRNA IPA-3 GDSC1000 pan-cancer AAC -0.095 0.005
mRNA paclitaxel CCLE pan-cancer AAC -0.13 0.006
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.14 0.006
Download CSV